2024-05-13 | Sale | G1 Therapeutics, Inc. GTHX | Chief Operating Officer | 8,151 0.0162% | $4.79 | $39,034 | -30.3% | |
2024-01-04 | Sale | G1 Therapeutics, Inc. GTHX | Chief Operating Officer | 721 0.0013% | $2.94 | $2,121 | +18.41% | |
2024-01-03 | Sale | G1 Therapeutics, Inc. GTHX | Chief Operating Officer | 3,019 0.0061% | $3.12 | $9,416 | +24.83% | |
2023-07-05 | Sale | G1 Therapeutics, Inc. GTHX | Chief Operating Officer | 1,361 0.0026% | $2.45 | $3,339 | +2.21% | |
2023-01-05 | Sale | G1 Therapeutics, Inc. GTHX | Chief Operating Officer | 729 0.0015% | $5.41 | $3,942 | -49.81% | |
2023-01-04 | Sale | G1 Therapeutics, Inc. GTHX | Chief Operating Officer | 1,639 0.0032% | $5.58 | $9,138 | -52.75% | |
2022-07-05 | Sale | G1 Therapeutics, Inc. GTHX | Chief Operating Officer | 648 0.0013% | $5.17 | $3,351 | +2.84% | |
2022-01-05 | Sale | G1 Therapeutics, Inc. GTHX | Chief Operating Officer | 1,445 0.0036% | $10.61 | $15,334 | -16.8% | |
2018-12-03 | Sale | G1 Therapeutics, Inc. GTHX | SVP of Development Operations | 7,046 0.0139% | $26.03 | $183,375 | -38.61% | |
2018-11-05 | Sale | G1 Therapeutics, Inc. GTHX | SVP of Development Operations | 7,038 0.0121% | $27.52 | $193,670 | -48.95% | |
2018-10-03 | Sale | G1 Therapeutics, Inc. GTHX | SVP of Development Operations | 7,038 0.0116% | $31.34 | $220,606 | -53.6% | |
2018-09-04 | Sale | G1 Therapeutics, Inc. GTHX | SVP of Development Operations | 7,038 0.0129% | $36.74 | $258,606 | -58.78% | |
2018-08-03 | Sale | G1 Therapeutics, Inc. GTHX | SVP of Development Operations | 7,038 0.013% | $32.05 | $225,603 | -52.19% |